parotid adenocarcinoma
Conditions
Interventions
Intensity-modulated radiation therapy (IMRT) group:None
I-125 particle brachytherapy group:None
Sponsors
Peking University Hospital of Stomatology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. The tumor originated in the parotid gland; 2. Pathologic findings of salivary gland carcinoma after surgical treatment; 3. Compliance with the indications for postoperative radiotherapy; 4. Voluntary participation with written informed consent; 5. No serious systemic disease Karnofsky score >= 60;
Exclusion criteria
Exclusion criteria: 1. Previous history of head and neck radiotherapy or chemotherapy for systemic tumors; 2. Those who are currently being treated with other effective programs; 3. History of distant or systemic metastases; 4. History of other head and neck malignancies within 5 years; 5. Clinically significant cardiovascular or cerebrovascular disease, or uncontrolled systemic disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DFS rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival;quality of life;adverse reaction; | — |
Countries
China
Contacts
Public ContactJie Zhang
Peking University Hospital of Stomatology
Outcome results
None listed